Foghorn reported $267.4 million in cash and equivalents as of September 30, 2024, which is expected to fund operations into ...

One stage of drug development is testing on lab-grown cell cultures, which are usually grown on a flat surface, like a microscope slide. However, printing cells in 3D can potentially make tests ...